ARAVIVE, INC EBITDA

EBITDA of ARAV for past 10 years: annual, quarterly and twelve month trailing (TTM) including EBITDA growth rates and interactive chart. Earnings before interest, tax, depreciation and amortization (EBITDA) is a measure of a company's operating performance. Essentially, it's a way to evaluate a company's performance without having to factor in depreciation, interest expenses (debt), writedowns or other accounting measures and taxes. EBITDA, however, can be misleading because it strips out the cost of capital investments like property, plant, and equipment. To calculate EBITDA, take operating profit (also called EBIT) and add back depreciation and amortization.

Highlights and Quick Summary

  • EBITDA for the quarter ending September 30, 2023 was $-8.69 Million (a -29.7% decrease compared to previous quarter)
  • Year-over-year quarterly EBITDA decreased by -55.75%
  • Annual EBITDA for 2022 was $-70 Million (a 76.31% increase from previous year)
  • Annual EBITDA for 2021 was $-39.7 Million (a 71.23% increase from previous year)
  • Annual EBITDA for 2020 was $-23.2 Million (a 8.91% increase from previous year)
  • Twelve month EBITDA ending September 30, 2023 was $-58.4 Million (a -11.56% decrease compared to previous quarter)
  • Twelve month trailing EBITDA decreased by -16.52% year-over-year
Trailing EBITDA for the last four month:
30 Sep '23 30 Jun '23 31 Mar '23 31 Dec '22
$-58.4 Million $-66 Million $-72.9 Million $-70 Million
Visit stockrow.com/ARAV for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EBITDA of ARAVIVE, INC

Most recent EBITDAof ARAV including historical data for past 10 years.

Interactive Chart of EBITDA of ARAVIVE, INC

ARAVIVE, INC EBITDA for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 $-8.69 $-12.37 $-17.7 – –
2022 $-19.64 $-16.33 $-19.21 $-14.78 $-69.95
2021 $-13.43 $-11.32 $-7.16 $-7.77 $-39.68
2020 $-9.51 $-10.25 $-4.7 $-10.19 $-23.17
2019 $-5.04 $-6.87 $-3.75 $-5.61 $-21.28
2018 $-52.52 $-5.48 $-9.32 $-8.4 $-31.84
2017 $-8.77 $-49.66 $-36.14 $-29.61 $-84.17
2016 $-22.44 $-27.36 $-22.25 $-24.05 $-96.11
2015 $-20.19 $-20.46 $-19.44 $-22.23 $-82.31
2014 $-15.89 $-14.05 $-8.49 $-7.58 $-46.01
2013 $-5.88 $-5.26 $-3.98 $-4.06 $-19.15
2012 – – – – $-12.57

Business Profile of ARAVIVE, INC

Sector: Healthcare
Industry: Biotechnology
© stockrow.com